vaccin
play
indispens
role
protect
variou
infecti
diseas
viru
bacteria
protozoa
elicit
antigenspecif
cell
humor
antibodi
respons
vaccin
program
help
erad
smallpox
rinderpest
diseas
poliomyel
verg
erad
current
inactiv
vaccin
eg
rabi
influenza
foot
mouth
diseas
live
attenu
vaccin
eg
poliomyel
measl
mump
rubella
rota
influenza
infecti
bursal
diseas
viru
newcastl
diseas
viru
infecti
bronchiti
viru
vaccin
bird
recombin
protein
vaccin
eg
hepat
b
licens
use
human
anim
addit
genet
modifi
vaccin
viruslik
particl
dna
vaccin
variou
stage
preclin
clinic
trial
adjuv
play
import
role
enhanc
magnitud
durat
immun
vaccin
live
vaccin
requir
adjuv
selfrepl
pathogen
provid
requir
signal
activ
immun
system
howev
inactiv
vaccin
recombin
protein
vaccin
requir
adjuv
boost
immunogen
vaccin
antigen
current
irrespect
vaccin
candid
aluminum
adjuv
adjuv
licens
human
use
worldwid
adjuv
oilinwat
emuls
liposom
tolllik
receptor
agonist
licens
particular
vaccin
combin
howev
aluminum
adjuv
induc
humor
cellular
immun
respons
also
effect
protect
vaccin
yet
avail
mani
emerg
reemerg
viral
diseas
therefor
obviou
need
identif
novel
molecular
adjuv
induc
cellular
humor
immun
respons
review
present
overview
role
regulatori
cell
treg
immunosuppressor
immun
respons
virus
identif
valid
one
tregbas
adjuv
target
boost
protect
immun
viral
diseas
vaccin
abil
vaccin
confer
protect
evalu
basi
specif
immun
respons
magnitud
durat
immun
elicit
gener
step
process
mount
immun
respons
vaccin
follow
pattern
infect
pathogen
thu
cooper
member
innat
immun
compart
antigen
present
cell
apc
nk
cell
adapt
immun
compart
b
cell
critic
elicit
protect
immun
respons
vaccin
cellular
immun
play
import
role
clearanc
pathogeninfect
cell
antibodi
clear
cellfre
pathogen
upon
immun
vaccin
antigen
recogn
profession
apc
dendrit
cell
dc
macrophag
monocyt
vaccin
antigen
express
variou
pathogenassoci
molecular
pattern
recogn
divers
patternrecognit
receptor
prr
apc
prr
includ
tlr
ctype
lectin
receptor
clr
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
mannos
receptor
nodlik
receptor
nlr
retinoid
acidinduc
genei
rigi
like
receptor
rlr
tlr
clr
present
surfac
endosom
apc
nlr
rlr
intracellular
locat
signal
prr
activ
canon
noncanon
nfjb
inflammasom
activ
result
phagocytosi
antigen
secret
immunomodulatori
inflammatori
cytokin
chemokin
product
pathogenkil
molecul
thu
divers
prr
locat
ensur
optim
activ
innat
immun
cell
activ
differenti
antigenspecif
cell
requir
four
differ
signal
signal
zero
repres
recognit
pathogen
apc
via
prr
lead
phagocytosisendocytosi
antigen
activ
apc
endocytos
extern
antigen
cleav
smaller
peptid
proteolyt
enzym
cathepsin
antigen
peptid
load
onto
mhc
class
ii
molecul
transport
surfac
apc
present
cell
antigen
peptid
recogn
cell
receptor
tcr
complex
signal
antigen
produc
endogen
replic
pathogen
within
apc
rout
proteasom
cleavag
present
via
mhc
class
cell
cytotox
lymphocyt
ctl
addit
process
call
crosspresent
dc
could
also
present
extern
antigen
context
mhc
class
molecul
cell
activ
apc
pathogen
also
lead
enhanc
surfac
express
variou
costimulatori
molecul
adhes
molecul
provid
costimulatori
signal
signal
cell
activ
addit
signal
form
immunomodulatori
polar
cytokin
secret
apc
determin
polar
cell
distinct
subtyp
induc
treg
cell
provid
help
cell
activ
ctl
clear
infect
cell
via
cytotox
program
cell
help
also
crucial
b
cell
activ
antibodi
product
cell
express
transcript
factor
tbet
signal
transduc
activ
transcript
produc
primarili
interferonc
ifnc
produc
apc
play
import
role
differenti
cell
immun
respons
primarili
cellmedi
ifnc
secret
cell
activ
macrophag
clear
intracellular
pathogen
cell
express
gatabind
protein
produc
import
b
cell
differenti
clearanc
extracellular
pathogen
parasit
cell
express
retino
acidrel
orphan
receptor
c
rorc
produc
granulocytemacrophag
colonystimul
factor
chemokin
herp
influenza
respiratori
syncyti
viru
rotaviru
flavivirus
hepat
b
viru
coronaviru
adenoviru
poxvirus
treg
adjuv
target
transform
growth
factorb
tgfb
key
cytokin
mediat
differenti
human
cell
expand
cell
stabil
differenti
popul
cell
import
protect
sever
extracellular
pathogen
includ
klebsiella
candida
treg
immunosuppressor
posit
transcript
factor
forkhead
box
play
regulatori
role
check
activ
immun
cell
prevent
inflammationassoci
tissu
damag
treg
critic
immun
homeostasi
immun
toler
defici
treg
defect
function
associ
autoimmun
diseas
inflamm
human
defici
treg
due
mutat
result
immun
dysregul
polyendocrinopathi
enteropathi
xlink
syndrom
sever
autoimmun
inflammatori
disord
treg
repres
minor
popul
within
cell
cell
phenotyp
treg
high
constitut
express
cytotox
tlymphocyt
induc
tcell
costimul
fig
govern
function
treg
inflammatori
cytokin
could
render
treg
dysfunct
treg
could
natur
deriv
thymu
induc
adapt
differenti
peripheri
cell
influenc
apc
tgfb
tgfb
critic
cytokin
express
rorc
inflammatori
cytokin
microenviron
determin
stabil
induc
treg
induc
treg
present
phenotyp
similar
natur
treg
howev
natur
treg
function
stabl
addit
gene
wide
demethyl
natur
treg
natur
treg
mostli
specif
selfantigen
induc
treg
specif
foreign
antigen
includ
pathogen
although
bona
fide
marker
treg
mice
human
also
express
transient
recent
activ
cell
thu
base
express
pattern
three
subpopul
cell
identifi
peripher
human
blood
potent
suppress
hi
activ
lo
rest
treg
cytokinesecret
nonsuppress
lo
nontreg
sever
mutual
nonexclus
cellular
molecular
mechan
propos
treg
immunosuppress
function
treg
mediat
solubl
factor
cellassoci
molecul
lymphocyteactiv
major
cellassoci
molecul
treg
tgfb
perforin
granzym
solubl
factor
implic
treg
function
treg
could
directli
inhibit
activ
prolifer
effector
cell
indirectli
suppress
apc
function
thu
treg
suppress
matur
dc
express
mhc
costimulatori
molecul
inflammatori
cytokin
chemokin
thu
suppress
apc
function
treg
inhibit
abil
apc
polar
effector
cell
treg
could
induc
cytotox
program
caus
apoptosi
target
cell
via
granzym
perforin
mediat
adhes
moleculemedi
interact
treg
induc
catabol
tryptophan
induc
indoleamin
dc
via
interact
tryptophan
catabol
lead
releas
kynurenin
potent
immun
suppressor
addit
treg
also
suppress
activ
macrophag
monocyt
b
cell
treg
present
secondari
lymphoid
tissu
peripher
tissu
skin
treg
import
prevent
tissu
damag
associ
excess
inflamm
follow
viral
infect
indic
studi
dengu
virusinfect
patient
sever
experiment
model
viru
infect
includ
respiratori
syncyti
viru
rsv
herp
simplex
howev
abil
suppress
apc
b
cell
treg
could
also
inhibit
protect
immun
respons
tabl
modul
apc
particular
weaken
function
dc
abil
secret
polar
cytokin
express
costimulatori
molecul
virus
could
support
expans
natur
treg
promot
differenti
induc
treg
cell
expens
differenti
toward
effector
cell
altern
virus
could
directli
target
treg
via
tlrstimul
direct
infect
case
felin
immunodefici
viru
fiv
pathway
virus
enhanc
prolifer
treg
suppress
function
augment
express
molecul
implic
immunosuppress
function
membranebound
tgfb
treg
shown
modul
virusspecif
primari
memori
cell
respons
prolifer
effector
cell
number
thu
treg
delay
clearanc
virus
enhanc
persist
contrari
deplet
treg
use
antibodi
infect
enhanc
ctl
respons
also
deplet
memori
treg
effector
treg
mice
secondari
infect
influenza
led
increas
magnitud
antigenspecif
memori
cell
respons
airway
cytokin
chemokin
express
similarli
neonat
murin
model
rotaviru
infect
deplet
natur
treg
viru
infect
led
augment
cell
respons
viru
prolifer
ifnc
secret
interestingli
model
prolifer
b
cell
also
increas
treg
also
diminish
immun
respons
vaccin
particular
hamper
develop
effect
immun
respons
follow
immun
poorli
immunogen
vaccin
major
work
role
treg
vaccin
done
divers
tumor
model
immun
respons
dna
peptid
vaccin
inactiv
japanes
enceph
viru
vaccin
mice
compromis
presenc
treg
deplet
treg
enhanc
ctl
respons
vaccin
confer
greater
protect
upon
viral
challeng
enhanc
immunogen
cell
respons
upon
treg
deplet
also
observ
case
hepat
b
viru
recombin
subunit
protein
vaccin
fluvaccin
either
uvinactiv
influenza
viru
vaccin
specif
oligosaccharid
scgoslcfospao
influenza
viru
analysi
cellular
cytokin
profil
influenzavaccin
individu
also
suggest
treg
tgfb
contribut
inhibit
antiinfluenza
antibodi
respons
follow
vaccin
also
tickborn
enceph
hepat
b
vaccin
nonrespond
individu
increas
treg
upon
vaccin
sinc
activ
state
dc
time
encount
vaccin
antigen
determin
outcom
immun
respons
limit
influenc
treg
dc
junctur
could
lead
enhanc
immun
respons
poor
immunogen
vaccin
candid
although
deplet
treg
target
molecul
implic
treg
function
inhibit
use
peptid
inhibitor
provid
proof
principl
target
treg
vaccin
approach
might
use
human
major
reason
deplet
treg
block
function
could
break
immun
toler
caus
autoimmun
diseas
inflammatori
disord
appear
local
autoimmun
diseas
report
mice
consequ
treg
deplet
therefor
approach
target
treg
vaccin
purpos
deplet
treg
inhibit
function
transient
natur
small
molecul
antagonistbas
approach
explor
target
interact
chemokin
receptor
inhibit
transient
recruit
treg
site
immun
human
treg
murin
treg
express
chemokin
receptor
absent
cell
receptor
chemotact
agent
treg
vitro
vivo
chemokin
produc
huge
amount
nanogram
quantiti
dc
upon
activ
promot
contact
dc
cell
monoclon
antibodi
significantli
block
migrat
treg
thu
provid
evid
treg
could
target
via
chemokin
system
small
molecular
weight
antagonist
fig
identifi
silico
approach
block
migrat
treg
vitro
vivo
enhanc
dc
fig
importantli
use
antagonist
molecular
adjuv
vivo
experiment
model
amplifi
cellular
humor
immun
respons
inject
combin
mycobacterium
hepat
b
viru
plasmodium
yoelii
vaccin
antigen
addit
combin
antitumor
vaccin
antagonist
induc
antigenspecif
cell
tumor
immun
selfantigen
prevent
divis
treg
antagonist
alter
absolut
number
treg
compar
longer
halflif
week
monoclon
antibodi
use
deplet
treg
inhibit
function
halflif
antagonist
h
also
mice
inject
antagonist
biolog
marker
autoimmun
diseas
notic
signific
adjuv
activ
observ
divers
model
without
notic
side
effect
provid
strong
evid
sustain
adjuv
target
prophylaxi
therapeut
vaccin
data
also
provid
pointer
structur
biolog
silico
technolog
immunolog
tool
could
combin
identifi
potent
molecular
adjuv
might
wide
rang
util
vaccin
although
experiment
model
provid
evid
target
treg
would
enhanc
magnitud
durat
protect
immun
vaccin
pathogen
translat
result
clinic
hinder
due
fact
tilt
balanc
treg
would
deleteri
also
treg
share
surfac
marker
common
effector
cell
henc
mani
strategi
target
treg
lack
specif
also
express
cell
small
subset
cell
thu
antagonist
might
inhibit
antibodi
respons
use
context
booster
immun
might
prevent
interact
dc
memori
cell
cell
subset
lack
small
molecul
antagonist
could
use
enhanc
cellular
immun
respons
crucial
viral
diseas
cancer
dc
highli
concentr
epidermi
dermi
antagonist
could
use
vaccin
microneedlebas
immun
work
pharmacokinet
antagonist
optimum
dosefind
studi
experi
nonhuman
primat
necessari
carri
antagonist
clinic
use
vaccin
adjuv
dampen
immun
respons
vaccin
c
small
molecul
antagonist
block
interact
thu
prevent
inhibitori
action
treg
dc
consequ
dc
undergo
complet
activ
process
induc
maximum
immun
respons
vaccin
